new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated_20100107
Vertex Pharmaceuticals Incorporated_20100121
Vertex Pharmaceuticals Incorporated_20100128
Vertex Pharmaceuticals Incorporated_20131212
  

Vertex Pharmaceuticals Incorporated patents

Recent patent applications related to Vertex Pharmaceuticals Incorporated. Vertex Pharmaceuticals Incorporated is listed as an Agent/Assignee. Note: Vertex Pharmaceuticals Incorporated may have other listings under different names/spellings. We're not affiliated with Vertex Pharmaceuticals Incorporated, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "V" | Vertex Pharmaceuticals Incorporated-related inventors




Date Vertex Pharmaceuticals Incorporated patents (updated weekly) - BOOKMARK this page
03/16/17Methods of regioselective synthesis of 2,4-disubstituted pyrimidines
02/09/17Pyridone amides as modulators of sodium channels
01/26/17Prodrug of an ice inhibitor
12/29/16Prodrugs of pyridone amides useful as modulators of sodium channels
12/22/16Dna-pk inhibitors
12/08/16Process of preparing pharmaceutical compositions for the treatment of cftr mediated diseases
12/08/16Dna-pk inhibitors
12/08/16Triazoles for the treatment of demyelinating diseases
12/01/16Compounds useful as inhibitors of atr kinase
11/24/16Co-crystals and pharmaceutical compositions comprising the same
11/24/16Dna-pk inhibitors
11/17/16Modulators of atp-binding cassette transporters
11/10/16Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
11/10/16Pharmaceutical compositions for the treatment of cftr mediated diseases
11/10/16Compounds useful as inhibitors of atr kinase
11/03/16Modulators of atp-binding cassette transporters
10/27/16Compounds useful as inhibitors of atr kinase
10/27/16Imidazopyridazines useful as inhibitors of the par-2 signaling pathway
10/20/16Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof.
09/22/16Modulators of atp-binding cassette transporters
09/22/16Compounds useful as inhibitors of atr kinase
09/01/16Dna-pk inhibitors
09/01/16Formulations of azaindole compounds
09/01/16Inhibitors of influenza viruses replication
09/01/16Methods of preparing inhibitors of influenza viruses replication
08/18/16Mannose derivatives for treating bacterial infections
08/18/16Modulators of cystic fibrosis transmembrane conductance regulator
08/11/16Modulators of atp-binding cassette transporters
08/11/16Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
08/04/16Modulators of cystic fibrosis transmembrane conductance regulator
08/04/16Crystalline forms of c21h22cl2n4o2
08/04/16Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
07/28/16Selective inhibitor of phosphatidylinositol 3-kinase-gamma
07/14/16Pharmaceutical compositions for the treatment of cftr-mediated disorders
07/14/16Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
06/16/16Modulators for atp-binding cassette transporters
06/16/16Isotopically enriched azaindoles
06/09/16Methods of regioselective synthesis of 2,4-disubstituted pyrimidines
06/09/16Fused piperidine amides as modulators of ion channels
06/02/16Sulfonamides as modulators of sodium channels
06/02/16Inhibitors of influenza viruses replication
05/26/16Modulators of atp-binding cassette transporters
04/07/16Modulators of cystic fibrosis transmembrane conductance regulator
04/07/16Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator
03/17/16Correctors acting through msd1 of cftr protein
03/10/16Pharmaceutical compositions and administrations thereof
02/25/16Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
02/11/16Dosage units of 3-(6-(1-(2,2-difluorobenzo[d] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
02/04/16Correctors acting through msd1 of cftr protein
02/04/16Compounds useful as inhibitors of atr kinase and combination therapies thereof
01/28/16Pharmaceutical compositions and administrations thereof
01/28/16Pharmaceutical compositions and administrations thereof
01/14/16Azaindoles useful as inhibitors of janus kinases
01/14/16Compounds useful as inhibitors of atr kinase
01/14/16Prodrugs of pyridone amides useful as modulators of sodium channels
12/31/15Compounds useful as inhibitors of atr kinase
12/17/15Method for treating cancer using a combination of chk1 and atr inhibitors
12/10/15Compounds useful as inhibitors of atr kinase
11/26/15Prodrugs of modulators of abc transporters
11/26/15Compounds useful as inhibitors of indoleamine 2,3-dioxygenase
11/26/15Quinoline and quinazoline amides as modulators of sodium channels
11/26/15Azaindole derivatives as cftr modulators
11/19/15Amides as modulators of sodium channels
11/12/15Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
11/05/15Process for making modulators of cystic fibrosis transmembrane conductance regulator
Patent Packs
11/05/15Pharmaceutical compositions for the treatment of cftr-mediated disorders
11/05/15Modulators of atp-binding cassette transporters
10/22/15Compounds useful as inhibitors of atr kinase
10/15/15Compounds useful as inhibitors of atr kinase
10/15/15Compounds useful in cftr assays and methods therewith
10/08/15Processes and intermediates for producing azaindoles
10/08/15Prodrug of an ice inhibitor
10/01/15Processes for making compounds useful as inhibitors of atr kinase
09/03/15Pyridone amides as modulators of sodium channels
09/03/15Pharmaceutical composition and administrations thereof
09/03/15Method for measuring atr inhibition mediated increases in dna damage
08/27/15Compounds useful as inhibitors of atr kinase
08/20/15Compositions for treatment of cystic fibrosis and other chronic diseases
08/06/15Process of producing cycloalkylcarboxamido-indole compounds
07/23/15Solid forms of (r)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamide
Patent Packs
07/09/15Modulators of atp-binding cassette transporters
07/09/15Treating seizures using ice inhibitors
07/09/15Inhibitors of influenza viruses replication
07/02/15Pharmaceutical compositions of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof
06/25/15Modulators of atp-binding cassette transporters
06/25/15Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
06/18/15Pharmaceutical compositions and administrations thereof
06/18/15Pharmaceutical compositions and administrations thereof
06/18/15Modulators of cftr
06/18/15Prodrugs of pyridone amides useful as modulators of sodium channels
06/11/15Compounds useful as inhibitors of atr kinase
06/11/15Compounds useful as inhibitors of atr kinase
06/04/15Compositions for treatment of cystic fibrosis and other chronic diseases
06/04/15Azaindoles useful as inhibitors of jak and other protein kinases
05/21/15Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof
05/21/15Pharmaceutical compositions and administrations thereof
05/07/15Modulators of cystic fibrosis transmembrane conductance regulator
04/30/15Modulators of atp-binding cassette transporters
04/23/15Dna-pk inhibitors
04/09/15Methods of regioselective synthesis of 2,4-disubstituted pyrimidines
04/09/15Processes and intermediates for producing azaindoles
04/02/15Modulators of atp-binding cassette transporters
03/19/15Pharmaceutical compositions for the treatment of cftr-mediated disorders
03/12/15Process for making modulators of cystic fibrosis transmembrane conductance regulator
03/05/15Pharmaceutical compositions
03/05/15Modulators of atp-binding cassette transporters
03/05/15Modulators of atp-binding cassette transporters
03/05/15Modulators of atp-binding cassette transporters
02/19/15Compounds useful as inhibitors of atr kinase
02/05/15Thiophene-carboxamides useful as inhibitors of protein kinases
Social Network Patent Pack
01/29/15Compounds useful as inhibitors of atr kinase
01/29/15Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis
01/29/15Modulators of atp-binding cassette transporters
01/22/15Pharmaceutical composition and administrations thereof
01/22/15Morpholine-spirocyclic piperidine amides as modulators of ion channels
01/22/15Modulators of atp-binding cassette transporters
01/08/15Pharmaceutical composition and administrations thereof
01/01/15Pyran-spirocyclic piperidine amides as modulators of ion channels
01/01/15Solid forms of (r)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-lndol-5-yl)-cyclopropanecarboxamide
12/18/14Heteroaryl derivatives as cftr modulators
Patent Packs
12/18/14Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
11/20/14Modulators of atp-binding cassette transporters
10/30/14Pharmaceutical compositions and administrations thereof
10/23/14Deazapurines useful as inhibitors of janus kinases
10/16/14Biomarkers for hcv infected patients
10/16/14Methods of stereoselective synthesis of substituted nucleoside analogs
10/09/14Modulators of cystic fibrosis transmembrane conductance regulator
09/25/14Compounds useful as inhibitors of atr kinase
09/18/14Mannose derivatives for treating bacterial infections
09/18/14Dna-pk inhibitors
09/18/14Dna-pk inhibitors
09/11/14Pharmaceutical composition and administrations thereof
09/11/14Process for making modulators of cystic fibrosis transmembrane conductance regulator
09/04/14Pyrimidine compounds as tuberculosis inhibitors
09/04/14Azaindoles useful as inhibitors of jak and other protein kinases
08/28/14Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
08/28/14Benzimidazole analogues for the treatment or prevention of flavivirus infections
08/28/14Methods for treating inflammatory diseases and pharmaceutical combinations useful therefor
08/28/14Mannose derivatives for treating bacterial infections
08/28/14Prodrugs of modulators of abc transporters
08/21/14Modulators of cystic fibrosis transmembrane conductance regulator
08/21/14Modulators of cystic fibrosis transmembrane conductance regulator vpi
08/21/14Thiophene compounds
08/21/14Thiophene compounds
08/21/14Formulations of thiophene compounds
08/14/14Quinoline and quinazoline amides as modulators of sodium channels
08/07/14Kinase inhibitors
08/07/14Compounds useful as inhibitors of janus kinases
08/07/14Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
08/07/14Amides as modulators of sodium channels
Patent Packs
07/31/14Pyridone amides as modulators of sodium channels
07/24/14Tricyclic heteroaryl compounds useful as inhibitors of janus kinase
07/24/14Modulators of atp-binding cassette transporters
07/24/14Dosage units of 3-(6-(1-(2,2-difluorobenzo[d] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
07/24/14Methods for preparation of thiophene compounds
07/17/14Methods for amplifying hepatitis c virus nucleic acids
07/03/14Pharmaceutical compositions
07/03/14Modulators of atp-binding cassette transporters
07/03/14Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
07/03/14Process for preparing modulators of cystic fibrosis transmembrane conductance regulator
06/19/14Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
06/19/14Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinases
06/12/14Modulators of atp-binding cassette transporters
06/12/14Pharmaceutical compositions for the treatment of cftr mediated diseases
06/12/14Compositions of targeted drug development
06/05/14Modulators of atp-binding cassette transporters
06/05/14Modulators of atp-binding cassette transporters
06/05/14Automated developer for immuno-stained biological samples
05/29/14Pyrazolopyridine kinase inhibitors
05/22/14Inhibitors of influenza viruses replication
Social Network Patent Pack
05/22/14Pharmaceutical compositions and administrations thereof
05/22/14Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
05/08/14Treatment of hepatitis c virus with telaprevir (vx-950) in patients non-responsive to treatment with pegylated interferon-alpha 2a/2b and ribavirin
05/01/14Compositions for treatment of cystic fibrosis and other chronic diseases
05/01/14Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
05/01/14Modulators of cystic fibrosis transmembrane conductance regulator
04/24/14Pharmaceutical composition and administrations thereof
04/24/14Compounds useful as inhibitors of atr kinase
04/24/14Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide
04/17/14Mannose derivatives for treating bacterial infections
04/17/14Compounds useful as inhibitors of atr kinase
04/17/14Processes and intermediates
04/03/14Inhibitors of influenza viruses replication
04/03/14Formulations of (r)-1-(2,2-difluorobenzo[d] [1,3] dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamide
03/27/14Modulators of cystic fibrosis transmembrane conductance regulator
03/27/14Modulators of cystic fibrosis transmembrane conductance regulator
03/27/14Pharmaceutical compositions of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamide and administration thereof
03/20/14Modulators of atp-binding cassette transporters
03/20/14Modulators of atp-binding cassette transporters
03/13/14Modulators of atp-binding cassette transporters
Social Network Patent Pack
03/13/14Modulators of cystic fibrosis transmembrane conductance regulator
03/06/14Compounds and methods for the treatment or prevention of flaviviridae viral infections
02/27/14Inhibitors of serine proteases
02/27/14Modulators of atp-binding cassette transporters
02/20/14Analysis of hcv genotypes
02/20/14Modulators of atp-binding cassette transporters
02/13/14Sterilizing and deodorizing agents, their manufacture and uses
02/06/14Aminopyrimidines useful as kinase inhibitors
02/06/14Dihydrodiazepines useful as inhibitors of protein kinases
01/30/14Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
01/23/14Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof
01/23/14Azaindole derivatives as cftr modulators
01/16/14Compounds useful as protein kinase inhibitors
01/09/14Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
01/09/14Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
01/09/14Process for making modulators of cystic fibrosis transmembrane conductance regulator
01/02/14Inhibitors of influenza viruses replication
01/02/14Inhibitors of influenza viruses replication
12/26/13Azaindoles useful as inhibitors of jak and other protein kinases
12/26/13Ion channel modulators and methods of use
12/19/13Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels
12/19/13Pharmaceutical compositions and administrations thereof
12/12/13Pharmaceutical compositions and administrations thereof
12/12/13Modulators of atp-binding cassette transporters
12/05/13Process of producing cycloalkylcarboxamido-indole compounds
11/28/13Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
11/28/13Pyridyl derivatives as cftr modulators
11/28/13Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
11/21/13Azaindazoles useful as inhibitors of kinases
11/07/13Modulators of atp-binding cassette transporters
Social Network Patent Pack
11/07/13Modulators of atp-binding cassette-transporters
10/24/13Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
10/17/13Therapies for treating hepatitis c virus infection
10/17/13Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
10/10/13Solid forms of gyrase inhibitor (r)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl]urea
10/03/13Mannose derivatives for treating bacterial infections
09/26/13Tri-cyclic pyrazolopyridine kinase inhibitors
09/19/13Aminopyridines useful as inhibitors of protein kinases
09/12/13Azaindoles useful as inhibitors of janus kinases
09/05/13Modulators of cystic fibrosis transmembrane conductance regulator
09/05/13Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide
09/05/13Amides useful as inhibitors of voltage-gated sodium channels
08/29/13Pharmaceutical composition and administrations thereof
08/08/13Compounds and methods for the treatment or prevention of flavivirus infections
08/01/13High potency formulations of vx-950
08/01/13Modulators of cystic fibrosis transmembrane conductance regulator
07/25/13Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
07/25/13Compounds and methods for the treatment or prevention of flavivirus infections
07/18/13Compounds and methods for the treatment or prevention of flavivirus infections
07/18/13Compositions useful as inhibitors of voltage-gated sodium channels
07/18/13Pyridones useful as inhibitors of kinases
07/18/13Modulators of atp-binding cassette transporters
07/18/13Processes for making compounds useful as inhibitors of atr kinase
07/11/13Inhibitors of serine proteases
07/04/13Processes and intermediates
06/27/13Modulators of atp-binding cassette transporters
06/20/13Hcv ns5b protease mutants
06/20/13Benzimidazole analogues for the treatment or prevention of flavivirus infections
06/20/13Pharmaceutical compositions and administrations thereof







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Vertex Pharmaceuticals Incorporated in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Vertex Pharmaceuticals Incorporated with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';